Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tremor and Craniofacial Dystonia Preceding Ataxia in SCA43: Expanding the Phenotypic Spectrum of MME-related Ataxia.

Cerebellum (London, England)·2026
Same author

An international 20 country patient and physician survey of the usability and acceptability of Stepped Care pathway in Parkinson's disease.

Scientific reports·2025
Same author

Insights from Magnetic Evoked Field Analysis in Patients with Wilson's Disease.

Neurology India·2022
Same author

The Spectrum of Movement Disorders in Tertiary Care Centers in India: A Tale of Three Cities.

Annals of Indian Academy of Neurology·2022
Same author

PRRT2 Gene Mutations in Indian Paroxysmal Kinesigenic Dyskinesia Patients.

Annals of Indian Academy of Neurology·2021
Same author

Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life.

Scientific reports·2021

Related Experiment Video

Updated: Jun 18, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Wilson's disease: An Indian perspective.

A B Taly1, L K Prashanth, S Sinha

  • 1Department of Neurology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore, Karnataka, India. abtaly@yahoo.com

Neurology India
|November 26, 2009
PubMed
Summary
This summary is machine-generated.

Wilson's disease (WD) is a genetic disorder causing copper buildup. Early diagnosis and treatment significantly reduce mortality, but challenges in long-term care and medication access persist.

Related Experiment Videos

Last Updated: Jun 18, 2026

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
06:52

Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders

Published on: April 28, 2023

Area of Science:

  • Genetics and rare diseases
  • Hepatology and metabolic disorders
  • Neurology and systemic manifestations

Background:

  • Wilson's disease (WD) is an autosomal recessive genetic disorder.
  • It results from a defect in copper transport, leading to toxic copper accumulation in organs like the liver, brain, and kidneys.
  • WD affects children and young adults, proving fatal without timely de-coppering therapy.

Observation:

  • Over the past century, awareness and diagnostic capabilities for WD have improved, enabling earlier detection, even pre-symptomatically.
  • Research in India has detailed WD's phenotypic variations, including neurological and systemic effects, and explored genetic factors.
  • Studies have assessed treatment impacts, such as zinc sulfate's effect on quality of life.

Findings:

  • Despite advances, diagnostic delays and treatment protocol disagreements (e.g., penicillamine use) remain significant clinical challenges.
  • Understanding WD's clinical heterogeneity through markers, imaging, and genetic analysis is ongoing.
  • Long-term patient care, medication accessibility for impoverished patients, and disease-related mortality/morbidity are critical concerns.

Implications:

  • Enhanced diagnostic strategies and awareness are crucial for early Wilson's disease intervention.
  • Further research into optimal, accessible therapeutic protocols is needed to improve patient outcomes.
  • Addressing socioeconomic barriers to medication access is vital for managing this treatable genetic disorder.